Sign In
Buy CTLT
$63.49
+0 (+0%)
At Close: Mar 14, 2025
Why Catalent Stock Was a Disaster Today
05:27pm, Monday, 08'th May 2023
Investors expecting the contract drug specialist to publish its latest quarterly results on Tuesday were sorely disappointed. Once it does release results, the company will deliver weaker guidance tha
CTLT Stock Sinks 25% After Catalent Delays Earnings Release
02:57pm, Monday, 08'th May 2023
A biotechnology firm that can't catch a break, Catalent (NYSE: CTLT ) added to its growing list of problems with a delay of its fiscal third-quarter earnings report. Originally, management scheduled t
Why Wall Street Took a Hit From These 2 NYSE Stocks
12:43pm, Monday, 08'th May 2023
Markets were mixed just after midday on Monday. Catalent delayed a key quarterly report filing, pointing to a big hit to revenue and profit.
Catalent Delays Earnings Report, Expects to 'Significantly' Cut Guidance
09:09am, Monday, 08'th May 2023
Catalent anticipates a significant reduction to both its fiscal 2023 revenue and adjusted earnings before interest, taxes, depreciation and amortization guidance.
Catalent Delays Third Quarter Results and Conference Call and Provides Update on Fiscal 2023 Guidance
07:45am, Monday, 08'th May 2023
SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it will be delaying th
Is It Time to Buy the S&P 500's 3 Worst-Performing April Stocks?
05:31am, Wednesday, 03'rd May 2023
Drugmaker Catalent saw production challenges a company of its caliber shouldn't be facing. Enphase Energy's current quarter isn't as healthy as expected, but the solar power evolution is still strong.
Four Stocks Turn $10,000 Into $50,000 In Four Months
08:00am, Monday, 01'st May 2023
April turned out to be great month for most S&P 500 investors. But it was stupendous for those who picked the best stocks.
Catalent (CTLT) Stock Jumps 6.8%: Will It Continue to Soar?
03:06am, Monday, 01'st May 2023
Catalent (CTLT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in
Why Catalent Stock Tumbled by Nearly 6% on Tuesday
05:11pm, Tuesday, 25'th Apr 2023
The contract drug manufacturer's awful April continued with a new analyst price target cut. Bank of America reduced its level by nearly 40%.
Catalent: A Promising Upside Opportunity In Play Despite Current Woes
02:20pm, Thursday, 20'th Apr 2023
Catalent: A Promising Upside Opportunity In Play Despite Current Woes.
Why Catalent Stock Dove More Than 7% Today
06:33pm, Tuesday, 18'th Apr 2023
A pair of analysts cut their price targets on the shares. One of the cuts was rather aggressive.
Three stocks making headlines today: JNJ, CTLT, LMT
04:47pm, Tuesday, 18'th Apr 2023
Aptus Capital Advisors' Dave Wagner joins 'Power Lunch' to discuss how to trade three stocks making headlines today: Johnson & Johnson, Catalent, and Lockheed Martin.
Catalent (CTLT) Declines on Profit Warnings and CFO Exit
03:14pm, Tuesday, 18'th Apr 2023
Catalent (CTLT) issues a profit warning for third-quarter fiscal 2023 amid supply chain disruptions and operational challenges. It also announces the departure of its CFO.
Why Catalent Stock Slumped on Monday
05:51pm, Monday, 17'th Apr 2023
A media report said that a potential suitor has abandoned its efforts to acquire the specialty healthcare services provider. That party isn't entirely giving up on its chase, however.
Catalent warns of production issues, finishes day as worst S&P 500 performer
07:57pm, Friday, 14'th Apr 2023
CNBC's Meg Tirrell joins 'Closing Bell: Overtime' to report on Catalent and Moderna.
